LJI study details measles virus neutralization

FHS
June 28, 2024
4:53 am

What happens when measles virus meets a human cell? The viral machinery unfolds in just the right way to reveal key pieces that let it fuse itself into the host cell membrane.

Mixed Results With Senolytic Agent for Retinal Disease

SEATTLE — A drug targeting senescent cells in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) produced mixed outcomes in two separate clinical

August 3, 2023

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

AstraZeneca’s Soliris initially obtained approval in the EU in 2017 to treat adults. Credit: AstraZeneca. The European Medicines Agency’s committee for medicinal products for human

June 27, 2023

Dr. Reddy’s, Torrent Pharma and Laurus Synthesis all land Form 483 letters following FDA inspections

In December the FDA hit India-based Torrent Pharmaceuticals, Laurus Synthesis and Dr. Reddy’s Laboratories each with Form 483 letters published on Dec. 28. This was

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.